BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35545793)

  • 1. Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study.
    Wang L; Ge L; You S; Liu Y; Ren Y
    J Cardiothorac Surg; 2022 May; 17(1):110. PubMed ID: 35545793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
    Moon MH; Moon YK; Moon SW
    Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
    Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
    Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcomes of segmentectomy vs lobectomy in pathologic stage IA (≤2 cm) invasive lung adenocarcinoma: A population-based study.
    Li F; Zhao Y; Yuan L; Wang S; Mao Y
    J Surg Oncol; 2020 Jun; 121(7):1132-1139. PubMed ID: 32108349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
    Wu L; Zhao W; Chen T; Yang Y
    J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.
    Shao S; Song G; Wang Y; Yi T; Li S; Chen F; Li Y; Liu X; Han B; Liu Y
    Front Oncol; 2022; 12():946800. PubMed ID: 36081555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A propensity score matching analysis of survival following segmentectomy or wedge resection in early-stage lung invasive adenocarcinoma or squamous cell carcinoma.
    Zhang Y; Sun Y; Chen H
    Oncotarget; 2016 Mar; 7(12):13880-5. PubMed ID: 26871600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival following segmentectomy or lobectomy in elderly patients with early-stage lung cancer.
    Zhang Y; Yuan C; Zhang Y; Sun Y; Chen H
    Oncotarget; 2016 Apr; 7(14):19081-6. PubMed ID: 26934652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segmentectomy versus lobectomy for small-sized pure solid non-small cell lung cancer.
    Li Z; Xu W; Pan X; Wu W; Chen L
    Thorac Cancer; 2023 Apr; 14(11):1021-1028. PubMed ID: 36882365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
    Gao L; Shen L; Wang K; Lu S
    Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the long-term outcomes of segmentectomy and lobectomy for stage IA1 lung adenocarcinoma in patients with or without previous malignancy of other organs: a population-based study.
    Bai W; Zhang J; Wang Y; Zhou M; Liu L; Wang G; Zhao K; Gao X; Li S
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):215-228. PubMed ID: 34596477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer.
    Hao B; Zhang L; Fan T; Liu B; Jiang W; Hu H; Geng Q
    Front Oncol; 2020; 10():661. PubMed ID: 32500023
    [No Abstract]   [Full Text] [Related]  

  • 14. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
    Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
    Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of stage I NSCLC (≤3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis.
    Qu X; Wang K; Zhang T; Shen H; Dong W; Liu Q; Du J
    J Thorac Dis; 2017 Nov; 9(11):4561-4573. PubMed ID: 29268526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.
    Kodama K; Higashiyama M; Okami J; Tokunaga T; Imamura F; Nakayama T; Inoue A; Kuriyama K
    Ann Thorac Surg; 2016 Feb; 101(2):504-11. PubMed ID: 26542438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy on the patients with non-small cell lung cancer: a propensity score matching study.
    Hwang Y; Kang CH; Kim HS; Jeon JH; Park IK; Kim YT
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):273-8. PubMed ID: 25406426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study.
    Zhang B; Liu R; Ren D; Li X; Wang Y; Huo H; Zhu S; Chen J; Song Z; Xu S
    Front Oncol; 2021; 11():610638. PubMed ID: 34026604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.